after anti-androgen review treatment the therapy records for expected orchiectomy, removal of testes to gastrointestinal duration of prevent testosterone upset treatment, and production breast tenderness consider luteinizing hormone gynecomastia permanence. releasing hormone decreased libido agonists (LHRH impotence analogs), which can hot flashes lower the testosterone after LHRH analogs as effectively as impotence orchiectomy such as hot flashes, and Lupron (leuprolide) gynecomastia. Zoladex (goserelin), and busrelin estrogens or drugs, which lower the level of testosterone second-line hormonal drugs, which are used when first-line hormone therapy fails anti-androgens, which block the ability of the body to use androgens, such as Eulexin (flutamide) Casodex (bicalutamide), and Nilandron (nilutamide), and combined hormone therapy, which is an anti-androgen combined with orchiectomy or an LHRH agonist (analog). chemotherapy Depending on the type Chemotherapy is used of chemotherapy used, for palliation as current there are multiple agents will not eradicate possible side effects. prostate cancer; therefore evaluate as 100 percent consider permanence
orchiectomy, the removal of testes to prevent testosterone production luteinizing hormone releasing hormone agonists (LHRH analogs), which can lower the testosterone as effectively as orchiectomy such as Lupron (leuprolide) Zoladex (goserelin), and busrelin estrogens or drugs, which lower the level of testosterone second-line hormonal drugs, which are used when first-line hormone therapy fails anti-androgens, which block the ability of the body to use androgens, such as Eulexin (flutamide) Casodex (bicalutamide), and Nilandron (nilutamide), and combined hormone therapy, which is an anti-androgen combined with orchiectomy or an LHRH agonist (analog). after anti-androgen therapy gastrointestinal upset breast tenderness gynecomastia decreased libido impotence hot flashes after LHRH analogs impotence hot flashes, and gynecomastia. review treatment records for expected duration of treatment, and consider permanence. chemotherapy Depending on the type of chemotherapy used, there are multiple possible side effects. Chemotherapy is used for palliation as current agents will not eradicate prostate cancer; therefore evaluate as 100 percent consider permanence
1-28-16_Key%20Changes_M21-1III_iv_4_SecI.docx